Huihui Li Selected Research

Cystatins

8/2022	Trichinella spiralis cystatin alleviates polymicrobial sepsis through activating regulatory macrophages.
1/2021	Schistosoma japonicum Cystatin Alleviates Sepsis Through Activating Regulatory Macrophages.
1/2021	Therapeutic Effect of Schistosoma japonicum Cystatin on Atherosclerotic Renal Damage.
5/2020	Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model.
5/2017	Therapeutic effect of Schistosoma japonicum cystatin on bacterial sepsis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huihui Li Research Topics

Disease

29	Neoplasms (Cancer) 03/2022 - 11/2012
17	Inflammation (Inflammations) 08/2022 - 08/2009
14	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2014
7	Breast Neoplasms (Breast Cancer) 02/2022 - 12/2013
6	Sepsis (Septicemia) 08/2022 - 08/2016
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2015
6	Atherosclerosis 01/2021 - 05/2015
6	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2014
5	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 05/2018
4	Fibrosis (Cirrhosis) 08/2022 - 01/2016
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
4	Heart Failure 01/2022 - 01/2020
4	Hypertension (High Blood Pressure) 01/2021 - 01/2018
4	Iron Overload 04/2020 - 01/2010
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2015
4	Thalassemia 01/2017 - 02/2010
4	Anemia 01/2017 - 02/2010
3	Infections 08/2022 - 01/2020
3	Triple Negative Breast Neoplasms 01/2022 - 12/2013
3	COVID-19 01/2021 - 01/2020
3	Body Weight (Weight, Body) 01/2021 - 01/2016
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2017
3	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2020
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 01/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2020 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2014
3	Iron Deficiencies 12/2016 - 01/2010
3	beta-Thalassemia (Cooley's Anemia) 02/2013 - 01/2010
2	Pneumonia (Pneumonitis) 03/2022 - 01/2021
2	Proteinuria 01/2022 - 11/2018
2	Myocarditis (Carditis) 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2018
2	Starvation 01/2021 - 01/2020
2	Lymphatic Metastasis 01/2021 - 01/2020
2	Leukemia 01/2021 - 08/2014
2	Carcinogenesis 01/2021 - 01/2020
2	Obesity 01/2021 - 08/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 05/2015
2	Cognitive Dysfunction 01/2020 - 05/2016
2	Schizophrenia (Dementia Praecox) 01/2020 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2018
2	Diarrhea 01/2020 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2010
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2017
9	CytokinesIBA 08/2022 - 04/2014
9	IronIBA 11/2020 - 01/2010
6	Therapeutic UsesIBA 08/2022 - 05/2017
6	LipidsIBA 01/2022 - 01/2016
6	Apolipoproteins E (ApoE)IBA 01/2021 - 08/2009
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2014
5	NitrogenIBA 08/2022 - 05/2017
5	CystatinsIBA 08/2022 - 05/2017
5	CreatinineIBA 08/2022 - 05/2017
5	Pharmaceutical PreparationsIBA 06/2022 - 01/2017
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2010
4	Urea (Carbamide)FDA LinkGeneric 08/2022 - 05/2017
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2015
4	Peptides (Polypeptides)IBA 12/2021 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 11/2012
4	Long Noncoding RNAIBA 01/2020 - 01/2019
4	HepcidinsIBA 01/2017 - 02/2010
3	AlbuminsIBA 08/2022 - 11/2018
3	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2021
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 12/2013
3	pyrotinibIBA 01/2022 - 01/2021
3	Angiotensin IIIBA 01/2021 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020 - 05/2016
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 08/2017 - 01/2014
3	CholesterolIBA 10/2016 - 12/2015
2	IpilimumabIBA 03/2022 - 01/2020
2	Troponin IIBA 01/2022 - 05/2020
2	Serum AlbuminIBA 01/2022 - 12/2013
2	EnzymesIBA 12/2021 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2021 - 01/2020
2	Cadherins (E-Cadherin)IBA 05/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Lapatinib (GW572016)FDA Link 01/2021 - 01/2021
2	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2021
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2021
2	Interleukin-22 (IL-22)IBA 11/2020 - 08/2019
2	Lipoproteins (Lipoprotein)IBA 07/2020 - 12/2013
2	SynucleinsIBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 04/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2020 - 01/2020
2	Immunoglobulin A (IgA)IBA 11/2018 - 01/2018
2	apatinibIBA 07/2018 - 05/2018
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 01/2016
2	Aldehyde Dehydrogenase 1 FamilyIBA 04/2017 - 12/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 04/2014

Therapy/Procedure

23	Therapeutics 03/2022 - 01/2010
11	Drug Therapy (Chemotherapy) 03/2022 - 01/2014
5	Ligation 08/2022 - 08/2016
5	Punctures 08/2022 - 08/2016
2	Intraperitoneal Injections 08/2022 - 05/2017
2	Liver Transplantation 11/2021 - 01/2020